Boule Diagnostics AB (publ) (BOUL.ST)
Stockholm · SEK · Healthcare · Medical Devices
SEK 1.10 (-1.35%) as of
Key statistics
- Market cap
- 42.72M
- Forward P/E
- 0.97
- EPS (TTM)
- -0.4500
- Dividend yield
- 0.00%
- 52-week range
- 0.9440 – 6.6400
- Beta
- 0.23
- Revenue (TTM)
- 461.29M
- Profit margin
- -0.60%
- Analyst target
- SEK 3.80
- Volume
- 136.98k
About Boule Diagnostics AB (publ)
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. It operates through Diagnostics and OEM Clinical Diagnostic Solutions. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics firms. The company was founded in 1956 and is headquartered in Spånga, Sweden.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Spånga, Sweden
- Employees
- 200
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.